The webinar “Introduction to In Vitro Permeation Testing (IVPT): Strengths and Weaknesses“, sponsored by Teledyne Hanson Research, will be presented on Thursday, April 7, 2022.
The participation at the webinar is free of charge but registration is needed for the attendance.
| Europe
14:00 / 2 PM CEST |
The Americas
20:00 / 8 PM CEST |
Asia/PacRim
3:00 / 3:00 AM CEST, April 8 |
| REGISTER | REGISTER | REGISTER |
The webinar is going to feature an introduction and critical study of in vitro permeation testing (IVPT) as it applies to in vitro skin penetration studies, and information on related new U.S. Food and Drug Administration guidance.
Speakers:
- Clive Roper, director of Roper Toxicology Consulting Ltd
- Frank Toner, associate director of In Vitro Dermal Services at Charles River Laboratories
The presentation will include vital information on draft guidance the FDA Office of Generics has provided, based on Acyclovir, to generate bioequivalence data without the use of clinical trials.
Presentation:
- What is IVPT?
- Why Perform IVPT?
- IVPT: The Five Steps
- Analytical method development
- Analytical method validation
- IVPT method development
- IVPT pilot
- IVPT pivotal
Following the presentation, you’ll have a valuable and unique opportunity to gain expert answers to your questions specific to IVPT in your lab. Teledyne Hanson representative Bruna Lousada also will offer information on the company’s IVPT-related instruments, products and services.
